IRF3 is required for T cell effector function52 to promote IFNγ-induced antitumor immunity to melanoma.53 IRF3 also inhibits colorectal54 and gastric cancer.55 These studies are consistent with our finding that LSD1 inhibition promotes IRF3 expression in OSCC cells. The gene discussed is IRF3; the disease is gastric cancer.